US regulators to weigh controversial peptides backed by RFK Jr

Read full story on Al Jazeera
Share
US regulators to weigh controversial peptides backed by RFK Jr
AI disclosure

Summary

FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.

Original reporting

Open original source

Related coverage

Read full article on Al Jazeera

Get the AFBytes Brief

Major stories, AI-assisted analysis, and what to watch next. Free, monthly, unsubscribe anytime.